# Melatonin Versus Placebo in the Lennox-Gastaut Syndrome: Neurophysiological and Neuropsychological Effects

> **NCT01370486** · PHASE4 · WITHDRAWN · sponsor: **Institution de Lavigny**

## Conditions studied

- Lennox-Gastaut Syndrome

## Interventions

- **DRUG:** melatonin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01370486
- **Lead sponsor:** Institution de Lavigny
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-08
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study did not received the approbation from Swissmedic. Therefore, the recruitment of participants never started.
- **Last updated:** 2022-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01370486

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01370486, "Melatonin Versus Placebo in the Lennox-Gastaut Syndrome: Neurophysiological and Neuropsychological Effects". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01370486. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*